ObsEva Company
ObsEva is a speciality biopharmaceutical company developing drugs for women’s reproductive medicine.
Investors
Technology:
Longevity FemTech
Industry:
Reproductive Health & Contraception
Headquarters:
Plan-les-ouates, Geneve, Switzerland
Founded Date:
01-01-2012
Employees Number:
11-50
Funding Status:
IPO
Investors Number:
17
Total Funding:
$228,371,119
Estimated Revenue:
Less than $1M
Last Funding Date:
2019-08-08
Last Funding Type:
Post-IPO Debt
Register and Claim Ownership